Skip to main content
Fig. 2 | Porcine Health Management

Fig. 2

From: Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs

Fig. 2

Serological evolution of antibodies against E. rhusiopathiae (2a), PPV (2b) and PRRSV (2c) by ELISA. Results are shown as average sample to positive (S/P) ratios in 2a and 2c and titers in 2b. Animals in group V (solid black line) were vaccinated with the combined administration of a PRRSV MLV vaccine and an inactivated PPV and Erysipelothrix rhusiopathiae vaccine at days 0, 21 and 147. Animals in group C (dotted grey line) were kept as controls receiving PBS using the same schedule. The cut-off for each ELISA is represented in each figure by a dotted line black. In all cases, different superscript letters (a,b) indicated statistically significant differences between groups (Kruskal-Wallis test; p < 0.05). Statistically significant differences within a group between a given sample and the previous one (Friedman test; p < 0.05) were shown as *

Back to article page

Porcine Health Management

ISSN: 2055-5660

Contact us